Nicholas Conrad Smith - Mar 1, 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 06:00 PM
Previous filing
Feb 7, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANRO Common Stock Award $0 +19.2K +1225.4% $0.00 20.7K Mar 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Employee Stock Option (Right to Buy) Award $0 +90K $0.00 90K Mar 1, 2024 Common Stock 90K $14.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. The RSUs shall vest in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Person's continuous service through each such vesting date.
F2 Each RSU represents a contingent right to receive one share of common stock.
F3 25% of the shares underlying the option shall vest on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.